ID: ALA4209646

Max Phase: Preclinical

Molecular Formula: C27H35FN6O

Molecular Weight: 478.62

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)NC(=O)N[C@H]1CC[C@@H](Nc2nc(NC(C)C)nc3ccc(-c4cccc(F)c4)cc23)CC1

Standard InChI:  InChI=1S/C27H35FN6O/c1-16(2)29-26-33-24-13-8-19(18-6-5-7-20(28)14-18)15-23(24)25(34-26)31-21-9-11-22(12-10-21)32-27(35)30-17(3)4/h5-8,13-17,21-22H,9-12H2,1-4H3,(H2,30,32,35)(H2,29,31,33,34)/t21-,22+

Standard InChI Key:  PMQDQOHCXXWAQC-SZPZYZBQSA-N

Associated Targets(Human)

NPR1 Tclin Atrial natriuretic peptide receptor A (169 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Npr1 Atrial natriuretic peptide receptor A (32 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 478.62Molecular Weight (Monoisotopic): 478.2856AlogP: 5.69#Rotatable Bonds: 7
Polar Surface Area: 90.97Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.59CX LogP: 5.00CX LogD: 4.93
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.35Np Likeness Score: -1.32

References

1. Iwaki T, Tanaka T, Miyazaki K, Suzuki Y, Okamura Y, Yamaki A, Iwanami M, Morozumi N, Furuya M, Oyama Y..  (2017)  Discovery and in vivo effects of novel human natriuretic peptide receptor A (NPR-A) agonists with improved activity for rat NPR-A.,  25  (24): [PMID:29153628] [10.1016/j.bmc.2017.11.006]

Source